These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8573899)

  • 1. The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients.
    Van Stone JC
    ASAIO J; 1995; 41(3):M713-6. PubMed ID: 8573899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postdialysis urea rebound: determinants and influence on dialysis delivery in chronic hemodialysis patients.
    Leblanc M; Charbonneau R; Lalumière G; Cartier P; Déziel C
    Am J Kidney Dis; 1996 Feb; 27(2):253-61. PubMed ID: 8659502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short, thrice-weekly hemodialysis is inadequate regardless of small molecule clearance.
    Twardowski ZJ
    Int J Artif Organs; 2004 Jun; 27(6):452-66. PubMed ID: 15291076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.
    Obi Y; Streja E; Rhee CM; Ravel V; Amin AN; Cupisti A; Chen J; Mathew AT; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
    Am J Kidney Dis; 2016 Aug; 68(2):256-265. PubMed ID: 26867814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.
    Korevaar JC; Jansen MA; Dekker FW; Boeschoten EW; Krediet RT
    Adv Perit Dial; 1999; 15():132-7. PubMed ID: 10682088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
    Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
    Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD.
    McKane W; Chandna SM; Tattersall JE; Greenwood RN; Farrington K
    Kidney Int; 2002 Jan; 61(1):256-65. PubMed ID: 11786108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent peritoneal dialysis: urea kinetic modeling and implications of residual kidney function.
    Guest S; Akonur A; Ghaffari A; Sloand J; Leypoldt JK
    Perit Dial Int; 2012; 32(2):142-8. PubMed ID: 22135316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The variable target model: a paradigm shift in the incremental haemodialysis prescription.
    Casino FG; Basile C
    Nephrol Dial Transplant; 2017 Jan; 32(1):182-190. PubMed ID: 27742823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low.
    Almond A; Siddiqui S; Robertson S; Norrie J; Isles C
    QJM; 2008 Aug; 101(8):619-24. PubMed ID: 18540009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2.
    Termorshuizen F; Dekker FW; van Manen JG; Korevaar JC; Boeschoten EW; Krediet RT;
    J Am Soc Nephrol; 2004 Apr; 15(4):1061-70. PubMed ID: 15034110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients.
    Zhang M; Wang M; Li H; Yu P; Yuan L; Hao C; Chen J; Kalantar-Zadeh K
    Am J Nephrol; 2014; 40(2):140-50. PubMed ID: 25171342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis urea rebound and membrane biocompatibility: accuracy of Kt/V estimations.
    Navarro JF; del Castillo N; Fernández JL; Macía ML; Méndez ML; Chahin J; García-Nieto V; Gallego E; Mora-Fernández C; García J
    Artif Organs; 1997 Feb; 21(2):91-5. PubMed ID: 9028489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores.
    Movilli E; Cancarini GC; Vizzardi V; Camerini C; Brunori G; Cassamali S; Maiorca R
    J Nephrol; 2003; 16(4):546-51. PubMed ID: 14696757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine may improve residual renal function in hemodialysis patients: a pilot study.
    Feldman L; Shani M; Sinuani I; Beberashvili I; Weissgarten J
    Hemodial Int; 2012 Oct; 16(4):512-6. PubMed ID: 22541137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the dialysis membrane on mortality of chronic hemodialysis patients.
    Hakim RM; Held PJ; Stannard DC; Wolfe RA; Port FK; Daugirdas JT; Agodoa L
    Kidney Int; 1996 Aug; 50(2):566-70. PubMed ID: 8840287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study.
    Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK
    Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function and nutritional status at the start of chronic dialysis treatment.
    Jansen MAM; Korevaar JC; Dekker FW; Jager KJ; Boeschoten EW; Krediet RT
    J Am Soc Nephrol; 2001 Jan; 12(1):157-163. PubMed ID: 11134262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
    Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
    Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.